Cost of miebo eye drops?

What’s the price of a bottle of Miebo?
A standard 5 mL bottle of Miebo (levocabastine 0.15 %) typically sells for about $70–$80 in the U.S. market. Prices can vary by pharmacy, location, and whether a discount card is used [1].

Do insurers help cover Miebo?
Most commercial health plans list Miebo as a covered ocular medication. The copay or coinsurance amount depends on the specific plan tier and pharmacy network. Patients should check with their pharmacy benefits manager for exact out‑of‑pocket costs.

Is there a cheaper alternative?
No generic levocabastine eye drops have reached the U.S. market yet, so Miebo remains the only available formulation. Some patients turn to other antihistamine eye drops (e.g., ketotifen or olopatadine) that have lower retail prices, but they have different dosing schedules and efficacy profiles.

Does the price change with volume?
Buying a larger bottle (e.g., 10 mL) often reduces the per‑drop cost slightly, but many pharmacies still price it near $140, keeping the unit cost similar to the 5 mL bottle. Multi‑buy promotions are rare for this drug.

Can I get samples or assistance programs?
The manufacturer offers a patient assistance program that may provide a free bottle to qualifying individuals with limited insurance coverage. Eligibility criteria usually include proof of income and a prescription from a licensed provider.

How does Miebo compare to other eye‑drop brands?
When compared to common OTC antihistamine drops (such as ketotifen 0.025 % or olopatadine 0.1 %), Miebo’s price is roughly 1.5–2 times higher. The higher cost reflects its prescription status and the proprietary formulation that delivers rapid relief of allergic conjunctivitis symptoms.

What happens if I run out of Miebo?
If you need a refill before the next scheduled visit, many pharmacies offer an express refill option that may require a quick online prescription verification. However, the same $70–$80 price will apply for each bottle.

Are there future pricing changes on the horizon?
A potential generic entrant could reduce the cost within the next 5–7 years if patent protection expires. Current data indicate the 20‑year patent term started in 2018, suggesting possible generic entry around 2038, though market competition could accelerate this timeline.

Where to find the most accurate, up‑to‑date price?
The best source for current U.S. pricing is the DrugPatentWatch database, which tracks pharmacy sales, manufacturer rebates, and patient‑assistance programs. Checking there can confirm the latest retail price and any available discounts.

---

Sources
[1] https://www.drugpatentwatch.com